Last year, the Texas-based nonprofit, in collaboration with Lyda Hill Philanthropies, invested $4 million into North Texas’ UT Southwestern Medical Center, bolstering efforts to transform groundbreaking research into viable companies.
Research Bridge Partners' CEO Lydia McClure, Ph.D. [Sources: Research Bridge Partners; MadamLead/istock]
Researchers at UT Southwestern Medical Center in Dallas have identified a compound that selectively eliminates cancer cells while sparing immune cells in a form of cell death known as ferroptosis, according to a news release.
UTSW said the findings, published in Science Translational Medicine earlier this year, could lead to new treatments for a wide variety of cancer types....
Daniel Siegwart, Ph.D., is Director of the Program in Genetic Drug Engineering, Professor of Biomedical Engineering and Biochemistry, and a member of the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern. [Photo: UT Southwestern]
Researchers at Dallas’ UT Southwestern Medical Center are leading three multicenter clinical trials focused on potential treatment for methamphetamine or cocaine addiction that are funded by the National Institute on Drug Abuse (NIDA)....
Three UT Southwestern Medical Center physician-scientists pursuing the prevention and treatment of disease that affect various stages of child development have been announced as the latest recipients of the Cary Council’s Early-Stage Research Grants....